Aromatherapy and Essential Oils (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (06/08/2017)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Human/Clinical Studies

Added text about a randomized controlled crossover clinical trial that investigated the effect of inhaled ginger essential oil on alleviating chemotherapy-induced nausea and vomiting in Asian women with breast cancer; aromatherapy administered as inhaled ginger essential oil for 5 days was associated with small, statistically significant, but not clinically significant, reductions in acute nausea but had limited effects on reducing vomiting or delaying nausea in 60 evaluable patients (cited Lua et al. as reference 8).

Summary of the Evidence for Aromatherapy and Essential Oils

Added text to Table 1 about a randomized controlled, single-blind, crossover clinical trial that investigated the effect of inhaled ginger essential oil on alleviating chemotherapy-induced nausea and vomiting in an Asian population with breast cancer (cited Lua et al. as reference 9).

This summary is written and maintained by the PDQ Integrative, Alternative, and Complementary Therapies Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Summary of the Evidence for Aromatherapy and Essential Oils

Next section >
About This PDQ Summary

Aromatherapy and Essential Oils (PDQ®)—Health Professional Version - National Cancer Institute